Travere Therapeutics Inc.

NASDAQ: TVTX · Real-Time Price · USD
18.82
0.59 (3.24%)
At close: Aug 15, 2025, 3:59 PM
19.25
2.28%
After-hours: Aug 15, 2025, 05:00 PM EDT

Travere Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-12.76M -41.23M -60.27M -54.75M -69.65M -136.06M -88.6M -115.78M -85.63M -86.33M -65.82M -69.66M -67.03M -75.97M -51.57M -35.64M -39.01M -53.87M
Depreciation & Amortization
14.02M 12.8M 12.09M 11.24M 10.35M 9.88M 11.85M 5.59M 13.9M 9.54M 9.3M 8.58M 8.11M 7.09M 6.05M 7.87M 6.62M 6.07M
Stock-Based Compensation
10.65M 11.49M 9.21M 8.02M 9.92M 9.76M 8.14M 10.73M 11.9M 13.47M 9.53M 8.83M 12.64M 8.19M 8.58M 6.99M 7.3M 7.91M
Other Working Capital
n/a -11.85M 8.7M -2.83M -66.78M -1.52M 20.17M -4.95M 1.27M -16.04M -173K 3.1M -3.8M -8.91M 18.38M 39.87M 1.73M 3.3M
Other Non-Cash Items
-6.93M -25.26M -4.16M -278K 94.45M 364K 100.45M -5.71M 1.09M 3.98M -6.19M 3.02M 5.38M 16.7M -6.54M 15.78M 4.27M 10.31M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -109.42M 49.58M -3.33M n/a n/a n/a n/a n/a 1.44M 1.06M 170K 1.45M
Change in Working Capital
n/a n/a 7.4M -6.74M -60.74M -2.95M 7.1M -3.56M -6.94M -22.07M -1.46M 9.7M 3.98M -11.32M 15.17M 36.01M 27.15M 1.65M
Operating Cash Flow
4.98M -42.19M -35.72M -42.51M -40.24M -119M -70.47M -59.13M -69.3M -81.12M -54.64M -39.52M -36.81M -55.32M -26.88M 32.06M 6.5M -26.47M
Capital Expenditures
-235K -11.78M -9.56M 18.38M -11.99M -6.47M -5.53M -5.56M -3.2M -27.97M -4.2M -7.63M -11.46M -5.27M -5.2M -5.37M -4.31M -9.27M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 12.65M 5.56M 3.2M 27.34M n/a -10.08M n/a 5.14M 14M 5.03M 4.2M 4.78M
Purchase of Investments
-64.37M n/a -125.76M n/a n/a n/a -62.65M -155.63M -122.47M -103.19M -84.28M -94.58M -180.25M -26.28M -44.94M -96.14M -157.16M -248.84M
Sales Maturities Of Investments
81.4M 53.16M 55.05M 54.32M 105.6M 111.36M 50M 87.7M 102.75M 94.12M 52.38M 112.29M 152.61M 64.72M 57.51M 134.03M 89.67M 152.4M
Other Investing Acitivies
-11.94M -11.87M -40K -26.57M -65M -6.47M -11.42M 201.25M -3.84M -27.34M -600K 10.08M -39.1M -5.14M -14M -5.03M -4.2M -4.78M
Investing Cash Flow
4.85M 41.29M -80.31M 46.13M 28.61M 104.9M -16.95M 133.32M -23.55M -37.04M -36.7M 10.08M -39.1M 33.16M 7.37M 32.52M -71.81M -105.71M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 95.44M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.48M 3.72M -525K -525K 782K -525K 124K -634K 2.27M 25.8M 551K 2.28M 831K -1.07M 2.44M 2.41M 402K 1.5M
Financial Cash Flow
1.48M 3.72M 139.12M 46K 782K -525K 124K -634K 2.27M 217M 551K 2.28M 831K 113.91M 33.21M 2.41M 303K 195.75M
Net Cash Flow
13.26M 3.36M 22.13M 4.12M -10.96M -14.93M -86.07M 73.37M -90.5M 99.69M -89.65M -28.42M -76.81M 90.82M 15.43M 67.04M -64.94M 63.46M
Free Cash Flow
4.75M -53.98M -45.28M -23.77M -52.24M -125.47M -76M -64.69M -72.5M -109.08M -58.84M -47.16M -48.27M -60.59M -32.08M 26.69M 2.19M -35.74M